H.PIO Co., Ltd. (KOSDAQ:357230)
South Korea · Delayed Price · Currency is KRW 2,605.00
+85.00 (3.37%)
At close: Apr 20, 2026
H.PIO Market Cap
H.PIO has a market cap or net worth of 106.08 billion as of April 21, 2026. Its market cap has increased by 0.98% in one year.
Market Cap
106.08B
Enterprise Value
111.44B
Revenue
258.19B
Ranking
n/a
PE Ratio
12.60
Stock Price
2,605.00
Market Cap Chart
Since May 14, 2021, H.PIO's market cap has decreased from 333.96B to 106.08B, a decrease of -68.24%. That is a compound annual growth rate of -20.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 107.53B | 7.64% |
| Dec 30, 2025 | 99.89B | -1.21% |
| Dec 30, 2024 | 101.11B | -37.21% |
| Dec 28, 2023 | 161.03B | 11.36% |
| Dec 29, 2022 | 144.60B | -46.67% |
| Dec 30, 2021 | 271.16B | -18.81% |
| May 14, 2021 | 333.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KOREA PHARMA | 131.32B |
| HYUNDAI BIOLAND | 130.35B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 128.85B |
| Pharos iBio | 124.15B |
| Cosmax Nbt | 103.60B |
| Daehan Nupharm | 102.46B |
| Sam-A Pharm. | 100.16B |
| Samik Pharmaceutical Company LTD. | 96.01B |